Page 1 | Search Results | Blood Advances | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Management of acquired hemophilia A: results from the Spanish registry

María-Eva Mingot-Castellano, Josep Pardos-Gea, Saturnino Haya, José-María Bastida-Bermejo, Dolors Tàssies, Ana Marco-Rico, Ramiro Núñez, Faustino García-Candel, María-Carmen Fernández-Sanchez de Mora, Inmaculada Soto, María-Teresa Álvarez-Román, Susana Asenjo, Marina Carrasco, Rafael Lluch-García, José-Manuel Martín-Antorán, Agustín Rodríguez-Alén, Elena Roselló, Laura Torres-Miñana, Shally Marcellini-Antonio, Ana Moretó-Quinana, José-Antonio Rodríguez-García, Reyes Aguinaco-Culebras, Nieves Alonso-Escobar, Carlos Cervero-Santiago, Núria Fernández-Mosteirín, María-Paz Martínez-Badás, Montserrat Pérez-Sánchez, Rocío Pérez-Montes, Ramón Rodríguez-González, Marisol Uribe-Barrientos, Isabel Socorro Caparrós-Miranda, Miriam Iglesias-Fernández, Ángela Baena, Manuel Rodríguez-López, Ana Sebrango-Sandia, Irene Vázquez-Fernández, Pascual Marco, on behalf of the Acquired Haemophilia Spanish Registry of the Spanish Society of ThrombosisHaemostasis (SETH)

Blood Adv (2021) 5 (19): 3821–3829.

https://doi.org/10.1182/bloodadvances.2021004626

Published: 2021

Includes: Supplemental data

Journal Articles

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Susanne Jung, Jochen Greiner, Stephanie von Harsdorf, Pavle Popovic, Roland Moll, Jens Schittenhelm, Kosmas Kandilaris, Volker Daniel, Alexander Kunz, Michael Schmitt, Peter Dreger

Blood Adv (2021) 5 (19): 3789–3793.

https://doi.org/10.1182/bloodadvances.2021004889

Published: 2021

Includes: Supplemental data

Journal Articles

Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation

Chikara Ogimi, Hu Xie, Alpana Waghmare, Masumi Ueda Oshima, Kanwaldeep K. Mallhi, Keith R. Jerome, Wendy M. Leisenring, Janet A. Englund, Michael Boeckh

Blood Adv (2021) 5 (7): 1903–1914.

https://doi.org/10.1182/bloodadvances.2020003865

Published: 2021

Includes: Supplemental data

Journal Articles

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Todd E. DeFor, Judith Witte, Mukta Arora, Jo-Anne Young, Daniel J. Weisdorf

Blood Adv (2021) 5 (5): 1352–1359.

https://doi.org/10.1182/bloodadvances.2020003937

Published: 2021

Includes: Supplemental data

Journal Articles

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma

Blood Adv (2020) 4 (18): 4337–4346.

https://doi.org/10.1182/bloodadvances.2020002553

Published: 2020

Includes: Supplemental data

Journal Articles

Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification

Ichiro Yonese, Chizuko Sakashita, Ken-Ichi Imadome, Tohru Kobayashi, Masahide Yamamoto, Akihisa Sawada, Yoshinori Ito, Noriko Fukuhara, Asao Hirose, Yusuke Takeda, Masanori Makita, Tomoyuki Endo, Shun-ichi Kimura, Masataka Ishimura, Osamu Miura, Shouichi Ohga, Hiroshi Kimura, Shigeyoshi Fujiwara, Ayako Arai

Blood Adv (2020) 4 (13): 2918–2926.

https://doi.org/10.1182/bloodadvances.2020001451

Published: 2020

Includes: Supplemental data

Journal Articles

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome

Nirav N. Shah, Bryon D. Johnson, Timothy S. Fenske, Renju V. Raj, Parameswaran Hari

Blood Adv (2020) 4 (10): 2119–2122.

https://doi.org/10.1182/bloodadvances.2020001626

Published: 2020

Journal Articles

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael C. Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael Pratta, Miguel-Angel Perales, Yi-Bin Chen, Gabrielle Meyers, John F. DiPersio

Blood Adv (2020) 4 (8): 1656–1669.

https://doi.org/10.1182/bloodadvances.2019001043

Published: 2020

Includes: Supplemental data

Journal Articles

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor

Blood Adv (2020) 4 (7): 1284–1295.

https://doi.org/10.1182/bloodadvances.2019001259

Published: 2020

Includes: Supplemental data

Journal Articles

Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management

Blood Adv (2020) 4 (4): 676–686.

https://doi.org/10.1182/bloodadvances.2019000952

Published: 2020

Journal Articles

Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD

Jonathan L. Golob, Martha M. DeMeules, Tillie Loeffelholz, Z. Z. Quinn, Michael K. Dame, Sabrina S. Silvestri, Michael C. Wu, Thomas M. Schmidt, Tina L. Fiedler, Matthew J. Hoostal, Marco Mielcarek, Jason Spence, Steven A. Pergam, David N. Fredricks

Blood Adv (2019) 3 (19): 2866–2869.

https://doi.org/10.1182/bloodadvances.2019000362

Published: 2019

Includes: Supplemental data

Journal Articles

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M. Vercellotti, Todd E. DeFor, Julie M. Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C. Conlon, Thomas A. Waldmann, David H. McKenna, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller

Blood Adv (2019) 3 (13): 1970–1980.

https://doi.org/10.1182/bloodadvances.2018028332

Published: 2019

Includes: Supplemental data

Journal Articles

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Gérard Socié, Noel Milpied, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger, Felipe Suarez, Mauricette Michallet, Philippe Lewalle, David Liens, Catherine Mathis, Eric Guemas, Jean-Paul Vernant

Blood Adv (2019) 3 (2): 184–186.

https://doi.org/10.1182/bloodadvances.2018028282

Published: 2019

Journal Articles

Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD

Blood Adv (2018) 2 (20): 2619–2628.

https://doi.org/10.1182/bloodadvances.2018020321

Published: 2018

Includes: Supplemental data

Journal Articles

How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD

Samantha M. Jaglowski, Bruce R. Blazar

Blood Adv (2018) 2 (15): 2012–2019.

https://doi.org/10.1182/bloodadvances.2018013060

Published: 2018

Journal Articles

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

Blood Adv (2018) 2 (14): 1765–1772.

https://doi.org/10.1182/bloodadvances.2018019414

Published: 2018

Journal Articles

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Spero R. Cataland, Peter J. Kourlas, Shangbin Yang, Susan Geyer, Leslie Witkoff, Haiwa Wu, Camila Masias, James N. George, Haifeng M. Wu

Blood Adv (2017) 1 (23): 2075–2082.

https://doi.org/10.1182/bloodadvances.2017009308

Published: 2017

Journal Articles

Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host disease

Zachariah DeFilipp, Rosalynn M. Nazarian, Areej El-Jawahri, Shuli Li, Jami Brown, Candice Del Rio, Melissa Smith, Betsy Valles, Karen K. Ballen, Steven L. McAfee, Jacalyn Rosenblatt, Joseph H. Antin, Corey S. Cutler, Yi-Bin Chen

Blood Adv (2017) 1 (22): 1919–1922.

https://doi.org/10.1182/bloodadvances.2017011239

Published: 2017

NARROW

Management of acquired hemophilia A: results from the Spanish registry

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma

Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor

Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management

Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD

How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only